Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01483079 · ClinicalTrials.gov registry record

Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)

A clinical trial of Prematurity, sponsored by Baylor College of Medicine.

Active
Registry status
51
Enrollment target
1
Study location

NCT01483079 is a study of Prematurity that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 51 participants, below the 209-participant average among 21 other Prematurity trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01483079, a study of Prematurity, is active but no longer recruiting, sponsored by Baylor College of Medicine.

ACTIVE NOT RECRUITING
Registry status
51 participants
Enrollment target
1
Study location

Study Summary

Human milk feeding is associated with great benefits to the health and development of infants, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk products for very low birth weight infants as an alternative to cow milk has risen dramatically in the past year. Purpose: To evaluate post-discharge growth and neurodevelopment of infants less than or equal to 1250 grams birth weight receiving an exclusive human milk protein diet.

Conditions Studied

Study Locations (1)

Texas

  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2011-12
Est. Completion 2026-12

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT01483079

The ClinicalTrials.gov registry entry for NCT01483079 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 209-participant average among 21 other Prematurity trials with a reported enrollment target (76% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prematurity appearing as the primary indexed condition, and to 0 interventions.

NCT01483079 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01483079 about?

NCT01483079 is a clinical study titled "Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)". Human milk feeding is associated with great benefits to the health and development of infants, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk products for very low birth weight infants as an alternative to cow...

What is the current status of trial NCT01483079?

This trial is currently active not recruiting. The enrollment target is 51 participants. The study started on 2011-12. Estimated completion is 2026-12.

What conditions does trial NCT01483079 study?

This clinical trial studies the following conditions: Prematurity.

Who is sponsoring clinical trial NCT01483079?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01483079 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.